Evidence map›Paper›PMID 24710539›Full record

ArticleCells2012

Human stem cells and articular cartilage regeneration.

Atsuyuki Inui, Takashi Iwakura, A Hari Reddi

Abstract read
In one paragraph

Article in Cells, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Scaffolded Chondrogenic Spheroid-Engrafted Model.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  3. Article
  4. Review
  5. Mechanisms of synovial joint and articular cartilage development.Cellular and molecular life sciences : CMLS · 2019
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Induced pluripotent stem cells in cartilage repair.World journal of orthopedics · 2016
    Article
  11. Article
  12. Article
  13. Scaffold-free, stem cell-based cartilage repair.Journal of clinical orthopaedics and trauma
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Atsuyuki InuiCenter for Tissue Regeneration and Repair, Department of Orthopaedic Surgery, School of Medicine, University of California Davis, 4635 Second Avenue, Research Building I Room 2000, Sacramento 95817, CA, USA. atsuyukiinui81@gamil.com.
Takashi IwakuraCenter for Tissue Regeneration and Repair, Department of Orthopaedic Surgery, School of Medicine, University of California Davis, 4635 Second Avenue, Research Building I Room 2000, Sacramento 95817, CA, USA. t_iwakura1978@yahoo.co.jp.
A Hari ReddiCenter for Tissue Regeneration and Repair, Department of Orthopaedic Surgery, School of Medicine, University of California Davis, 4635 Second Avenue, Research Building I Room 2000, Sacramento 95817, CA, USA. ahreddi@ucdavis.edu.

Funding

Engineering Lubrication in Tissue Engineered CartilageR01AR061496 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ATHANASIOU, KYRIACOS A, REDDI, AKEPATI HARI · 2011 to 2014
$1.3M
NIAMS NIH HHS R01 AR061496
6 · The paper itself

Abstract

The regeneration of articular cartilage damaged due to trauma and posttraumatic osteoarthritis is an unmet medical need. Current approaches to regeneration and tissue engineering of articular cartilage include the use of chondrocytes, stem cells, scaffolds and signals, including morphogens and growth factors. Stem cells, as a source of cells for articular cartilage regeneration, are a critical factor for articular cartilage regeneration. This is because articular cartilage tissue has a low cell turnover and does not heal spontaneously. Adult stem cells have been isolated from various tissues, such as bone marrow, adipose, synovial tissue, muscle and periosteum. Signals of the transforming growth factor beta superfamily play critical roles in chondrogenesis. However, adult stem cells derived from various tissues tend to differ in their chondrogenic potential. Pluripotent stem cells have unlimited proliferative capacity compared to adult stem cells. Chondrogenesis from embryonic stem (ES) cells has been studied for more than a decade. However, establishment of ES cells requires embryos and leads to ethical issues for clinical applications. Induced pluripotent stem (iPS) cells are generated by cellular reprogramming of adult cells by transcription factors. Although iPS cells have chondrogenic potential, optimization, generation and differentiation toward articular chondrocytes are currently under intense investigation.

Identifiers

PMID24710539
PMCPMC3901135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.